Minimally Invasive Cardiac Procedure Market Set to Grow at 7.75%...

Minimally Invasive Cardiac Procedure Market Set to Grow at 7.75% CAGR by 2030 – MarkNtel

Posted 2025-11-05 06:09:03

185

Global Minimally Invasive Cardiac Procedure Market: Key Dynamics, Size & Share Analysis

As per MarkNtel Advisors the Global Minimally Invasive Cardiac Procedure Market size was valued at around USD 15,928 million in 2024 and is projected to reach USD 24,932 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.75% during the forecast period, i.e., 2025-30.

Global Minimally Invasive Cardiac Procedure Market Trend:

Next-Generation Valves & Devices-Driven Cardiac Surgeries – The latest innovations in medical devices are revolutionizing the minimally invasive cardiac procedure industry. These models include the next-generation valves and related devices, which have increased operational efficiency, accuracy in the treatments, and patient recovery time.

Several companies, such as Boston, Medtronic, and Abbott, are actively involved in the manufacturing of these kinds of devices. For instance, Abbott (2025) has launched a Naviator Vision Valve, which is used in the minimally invasive transcatheter aortic valve replacement procedure, which is more efficient as compared to traditional open heart surgery. Additionally, the Medtronic company has received approval from the USFDA for the latest systems, called Evolut FX and Harmony TPV systems, used in catheter-based pulmonary valve replacement for the treatment of patients suffering from congenital heart diseases.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample: https://www.marknteladvisors.com/query/request-sample/minimally-invasive-cardiac-procedure-market.html

Minimally Invasive Cardiac Procedure Market Systems Market Segmentation:

-By Procedure Type

Aortic Valve Repair/Replacement- Market Size & Forecast 2020-2030, USD Million
Mitral Valve Repair/Replacement- Market Size & Forecast 2020-2030, USD Million
Surgical Radiofrequency Ablation for Atrial Fibrillation- Market Size & Forecast 2020-2030, USD Million
Tricuspid Valve Repair or Replacement- Market Size & Forecast 2020-2030, USD Million
Atrial Septal Defect (ASD) - Market Size & Forecast 2020-2030, USD Million
Ventricular Assist Device (VAD) Implantation- Market Size & Forecast 2020-2030, USD Million
Coronary Artery Bypass Grafting (CABG) - Market Size & Forecast 2020-2030, USD Million
Other- Market Size & Forecast 2020-2030, USD Million

-By Surgery Type

Robotic-assisted Surgery- Market Size & Forecast 2020-2030, USD Million
Thoracoscopic Surgery- Market Size & Forecast 2020-2030, USD Million

-By End User

Hospitals- Market Size & Forecast 2020-2030, USD Million
Ambulatory Surgical Centers (ASCs)- Market Size & Forecast 2020-2030, USD Million
Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million

Geographical Analysis of the Minimally Invasive Cardiac Procedure Market

-By Region

North America
South America
Europe
The Middle East and Africa
Asia-Pacific

North America is leading this market and holds about 45% of the market share. The supremacy of this region is due to the high number of cardiac patients in the region. As per the Heart Failure Society of America (2024), over 6.5 million individuals are living with heart failure, and this number is further projected to significantly increase in the United States.

Tap into future trends and opportunities shaping the Minimally Invasive Cardiac Procedure view the complete report: https://www.marknteladvisors.com/research-library/minimally-invasive-cardiac-procedure-market.html

Minimally Invasive Cardiac Procedure Market Recent Development:

2025: Medtronic Plc got approval from the U.S. Food and Drug Administration (FDA) for its new OmniaSecure™ defibrillation lead. This new device is made to be placed accurately inside the right side of the heart using a catheter.
2023: Boston Scientific Corporation introduced the WATCHMAN FLX™ Pro device, which received FDA approval to reduce stroke risk in patients with non-valvular atrial fibrillation. This latest iteration includes enhancements such as a thromboresistant coating, improved visualization markers, and an expanded size option to accommodate a broader range of patient anatomies.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Report Highlights Essential Insights for Strategic Decision-Making

Detailed market size, share, and forecast analysis
In-depth pricing trends and segment-wise cost evaluations
Key industry strategies, including innovation, partnerships, and acquisitions
Critical value chain analysis and stakeholder profiling
Regional import-export market insights and trade flow assessment
Thorough competitive benchmarking of top hearing aid manufacturers
Identification of new growth opportunities and niche market segments
Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Minimally Invasive Cardiac Procedure Market are:

Abbott Laboratories
GE HealthCare
Edwards Lifesciences Corporation
Siemens Healthineers
Medtronic PLC
Boston Scientific Corporation
Intuitive Surgical
Stryker Corporation
Terumo Corporation
Johnson & Johnson
Smith & Nephew
ReliantHeart, Inc.
Olympus Corporation
CardiacAssist, Inc.
Others

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/minimally-invasive-cardiac-procedure-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

Define objectives and research design
Collect data through surveys and interviews
Analyze and validate data using reliable tools
Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.